Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
MiNK Therapeutics, Inc. (INKT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
29 Aug 2023
AGENUS INC
10% Owner
MiNK Therapeutics, Inc.
(INKT)
21,734,888
+0%
29,678
$1.52
$45,015.59
BUY
24 Aug 2023
AGENUS INC
10% Owner
MiNK Therapeutics, Inc.
(INKT)
21,705,208
+0%
183,052
$1.54
$281,478.12
SELL
5 May 2023
ARMEN GARO H
Director
MiNK Therapeutics, Inc.
(INKT)
1,866,400
-5%
100,000
$0.95
$94,850.00
BUY
3 May 2023
AGENUS INC
10% Owner
MiNK Therapeutics, Inc.
(INKT)
21,594,848
+1%
250,362
$1.04
$260,189.02
BUY
2 May 2023
ARMEN GARO H
Director
MiNK Therapeutics, Inc.
(INKT)
1,978,010
+5%
100,000
$0.95
$94,850.00
BUY
18 Jul 2022
WIINBERG ULF
Director
MiNK Therapeutics, Inc.
(INKT)
298,300
+7%
20,000
$1.38
$27,646.31
BUY
19 Oct 2021
AGENUS INC
10% Owner
MiNK Therapeutics, Inc.
(INKT)
20,881,000
+7%
1,400,000
$12.00
$16,800,000.00
Home